DIEBOLD NIXDORF, Inc: Form 10-Q for the period ended Sep 30, 2022
Filed with the SEC on Nov 9, 2022 and accepted by EDGAR at Nov 9, 2022, 16:29 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2022-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2022-07-01 to 2022-09-30 | $810.4m | us-gaap:Revenues |
| Revenue | 9 months2022-01-01 to 2022-09-30 | $2.49bn | us-gaap:Revenues |
| Cost of revenue | 3 months2022-07-01 to 2022-09-30 | $616.6m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2022-01-01 to 2022-09-30 | $1.95bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2022-07-01 to 2022-09-30 | $193.8m | us-gaap:GrossProfit |
| Gross profit | 9 months2022-01-01 to 2022-09-30 | $539.9m | us-gaap:GrossProfit |
| Research and development | 3 months2022-07-01 to 2022-09-30 | $26.7m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2022-01-01 to 2022-09-30 | $92.1m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 3 months2022-07-01 to 2022-09-30 | $163.1m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Selling, general and administrative | 9 months2022-01-01 to 2022-09-30 | $557.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2022-07-01 to 2022-09-30 | $5.5m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2022-01-01 to 2022-09-30 | −$169.4m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2022-07-01 to 2022-09-30 | $50.7m | us-gaap:InterestExpense |
| Interest expense | 9 months2022-01-01 to 2022-09-30 | $148.4m | us-gaap:InterestExpense |
| Income tax | 3 months2022-07-01 to 2022-09-30 | $3.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2022-01-01 to 2022-09-30 | $119.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2022-07-01 to 2022-09-30 | −$49.8m | us-gaap:NetIncomeLoss |
| Net income | 9 months2022-01-01 to 2022-09-30 | −$432.1m | us-gaap:NetIncomeLoss |
| Basic EPS | 3 months2022-07-01 to 2022-09-30 | −$0.63 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2022-01-01 to 2022-09-30 | −$5.48 | us-gaap:EarningsPerShareBasic |
| Operating cash flow | 9 months2022-01-01 to 2022-09-30 | −$482.8m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Share repurchases | 9 months2022-01-01 to 2022-09-30 | $6.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Current assets | At period end2022-09-30 | $1.68bn | us-gaap:AssetsCurrent |
| Total assets | At period end2022-09-30 | $2.91bn | us-gaap:Assets |
| Current liabilities | At period end2022-09-30 | $3.90bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | At period end2022-09-30 | −$1.33bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000028823-22-000146. Last ingested by Listed: Oct 28, 2026, 07:18 ET. Listed shows no prices and gives no investment advice.